| 000 | 01632 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250512034047.0 | ||
| 264 | 0 | _c19861003 | |
| 008 | 198610s 0 0 eng d | ||
| 022 | _a0303-6995 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJenner, P | |
| 245 | 0 | 0 |
_aThe actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease. _h[electronic resource] |
| 260 |
_bJournal of neural transmission. Supplementum _c1986 |
||
| 300 |
_a11-39 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _a1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine |
| 650 | 0 | 4 | _a2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBenzazepines _xpharmacology |
| 650 | 0 | 4 | _aCallithrix |
| 650 | 0 | 4 |
_aCorpus Striatum _xdrug effects |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aDopamine _xphysiology |
| 650 | 0 | 4 |
_aErgolines _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLevodopa _xpharmacology |
| 650 | 0 | 4 | _aMacaca mulatta |
| 650 | 0 | 4 |
_aNeural Pathways _xdrug effects |
| 650 | 0 | 4 |
_aPargyline _xpharmacology |
| 650 | 0 | 4 | _aParkinson Disease |
| 650 | 0 | 4 |
_aParkinson Disease, Secondary _xchemically induced |
| 650 | 0 | 4 |
_aPyridines _xantagonists & inhibitors |
| 650 | 0 | 4 | _aQuinpirole |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aSaimiri |
| 650 | 0 | 4 |
_aSelegiline _xpharmacology |
| 650 | 0 | 4 | _aSpecies Specificity |
| 650 | 0 | 4 |
_aSubstantia Nigra _xdrug effects |
| 700 | 1 | _aMarsden, C D | |
| 773 | 0 |
_tJournal of neural transmission. Supplementum _gvol. 20 _gp. 11-39 |
|
| 999 |
_c3097563 _d3097563 |
||